Hi @Davisite
Curious about the reference in the pack to the FDA's Project Optimus (particularly the section I've circled in green) focusing on 'Quality of Life' and serious side-effects...
Cardio-protection is clearly the stand-out here, but other bisantrene benefits have been hinted at in the past.
For example, is it considered that nausea, vomitting and alopecia also fall into the 'Quality of Life' category?
The context for the question is this historic data for bisantrene;
(ref: https://citeseerx.ist.psu.edu/document?repid=rep1&type=pdf&doi=5f292b45d8b395dcbb86f962fa36bd4ef2ac625c)
Will RACE be tracking any of these side-effects?
Ann: Updated Strategy and Investor Presentation, page-239
-
- There are more pages in this discussion • 270 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
